logo-loader
RNS
ReNeuron Group PLC

ReNeuron Group plc - Corporate Update

RNS Number : 0291Z
ReNeuron Group plc
02 August 2024
 

2 August 2024

 

ReNeuron Group plc

("ReNeuron" or the "Company")

 

Corporate Update

 

ReNeuron Group plc (in administration) (AIM: RENE), a UK based leader in stem cell derived exosome technologies, provides the following corporate update in regards the Company's ongoing administration process ("Administration Process").

 

Update on Creditor Position

 

The Board of the Company took the decision to appoint Stephen Cork and Mark Smith of Cork Gully LLP as joint administrators to the Company (the "Joint Administrators") on 20 March 2024. Following their appointment, the Joint Administrators have been in discussion with ReNeuron's main creditors to the clarify the liabilities of the Company and ascertain the Company's financial solvency in light of its current cash resources. To date, there is a discrepancy between the amount the Company is able to pay to its creditors in settlement of the total liability to them and the quantum that the creditors are seeking.

 

Update on Staff

 

As part of the Administration Process, and in order to preserve value for creditors, the Joint Administrators have undertaken a cost rationalisation which has included, inter alia, the redundancy of several of the Company's employees as well as other cost cutting measures. Certain members of key Senior Management, including the Board of Directors and Randolph Corteling (Chief Scientific Officer) have remained with the business and continue to support the Joint Administrators.

 

Update on Financing Discussions

 

The Company, with the assistance of its brokers, have been seeking to identify potential investors that would be willing to invest in new equity capital to enable the Company to continue to trade as a going concern following an exit from administration (the "Proposed Fundraise"). Whilst discussions remain ongoing with potential investors, it is anticipated that completion of the Proposed Fundraise would be conditional on the Company exiting administration retaining sufficient funds to settle all of its known creditors, such that any new funds raised from investors could be used by the Company for its working capital requirements going forward post administration.

 

There can be no guarantees as to the outcome of the ongoing discussions with creditors and potential investors. Further updates will be provided in due course.

 

Enquiries:

 

Cork Gully LLP

+44 (0)20 7268 2150 or

Stephen Cork, Joint Administrator

reneuron@corkgully.com

Mark Smith, Joint Administrator


 


ReNeuron

www.reneuron.com/investors

Iain Ross, Executive Chairman

Via Walbrook PR





Allenby Capital Limited (Nominated Adviser and Broker)

+44 (0)20 3328 5656

James Reeve/George Payne/Dan Dearden-Williams (Corporate Finance)


Stefano Aquilino/Kelly Gardiner (Sales & Corporate Broking)




 




 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFFLTFIFIIS
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

3 min read